ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.
A central role in infectious diseases research for over 35 years
Supporting research to prevent, understand and treat infectious diseases
ANRS MIE three majors levels of action
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
Patient associations, next generation of scientists, quality and ethical approach, open science
Exceptional procedure for responding to emerging or re-emerging epidemics
Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.
Learn more about the diseases and pathogens covered by our research
Information on the projects we fund
Our workgroups bring together researchers and representatives of civil society
Guiding and advising innovative project leaders
The agency supports a number of research platforms and networks to federate and help shape research in its field
National and international research platforms supported by the agency and designed for the scientific community
Clinical research networks and networks of young researchers
Access to data and biological collections from research promoted by the agency
The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives
Partner sites, international global health research platforms, ad hoc partnerships
WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks
Strategic international projects and capacity-building programmes
Fighting epidemics: ANRS MIE leads WHO filovirus CORC
Collaboration with community stakeholders
Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players
Agency's current, forthcoming and completed calls for proposals
Find out the list of calls for projects previously funded by the agency
Find out the Start programme, here to support and guide the next generation of scientific researchers
Submit a project
Here you can find all the latest news and events relating to our areas of research.
Share:
Trier par
This second plenary session was held at the Institut Pasteur, Lille, on Monday January 29, 2024. This symposium was restricted to members of the CA Tuberculosis.
Dr Golriz Pahlavan, Chair of MSDAVENIR's Scientific Advisory Board, and Prof. Yazdan Yazdanpanah, Director of ANRS MIE, at the presentation of LSDengue and ARBOGEN on January 25, 2024.
The 2024 Work Programme of the Global Health EDCTP3 JU partnership was published in December 2023. It includes 7 calls for projects.
Using an animal model, researchers have identified a window of opportunity for introducing a treatment that promotes remission of HIV infection.
At the end of 2023, two training courses were delivered in Senegal to enhance the skills of various healthcare professionals and research players.
The generic Call for Proposals for HIV/AIDS, STIs, viral hepatitis and tuberculosis and the Conferences and Publications AAP have been open since January 15.
Through research, we can progress towards eliminating endemic infectious disease transmission and strengthen our preparedness for emerging infectious risks.
